Toxic epidermal necrolysis screening: Difference between revisions
Irfan Dotani (talk | contribs) (Created page with "__NOTOC__ {{Toxic epidermal necrolysis}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR Accordin...") |
(No difference)
|
Latest revision as of 15:59, 15 August 2018
Toxic epidermal necrolysis Microchapters |
Differentiating Toxic Epidermal Necrolysis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Toxic epidermal necrolysis screening On the Web |
American Roentgen Ray Society Images of Toxic epidermal necrolysis screening |
Risk calculators and risk factors for Toxic epidermal necrolysis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]